IL-1 alpha/IL-1F1 組換え体(リコンビナント)タンパク質 | Recombinant Human IL-1 alpha/IL-1F1

掲載日情報:2015/01/26 現在Webページ番号:111904

R&D Systems社製の高品質なIL-1 alpha/IL-1F1の組換え体タンパク質(Recombinant Human IL-1 alpha/IL-1F1)です。
本製品は研究用です。研究用以外には使用できません。

[在庫・価格 :2024年05月20日 08時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
IL-1α, Human, Recombinant
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 50
説明文
産生:E. coli,純度:>97%, by SDS-PAGE under reducing conditions and visualized by silver stain,由来動物:Human,M.W.:18 kDa,Genbank:3552,エンドトキシンレベル:<0.10 EU per 1 µg of the protein by the LAL method.
別名:Hematopoietin-1
Genbank No: 3552
Protein Accession No: Q53QF9
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
掲載カタログ

製品記事
関連記事
IL-1α, Human, Recombinant, Carrier-free
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
説明文
産生:E. coli,純度:>97%, by SDS-PAGE under reducing conditions and visualized by silver stain,由来動物:Human,M.W.:18 kDa,Genbank:3552,エンドトキシンレベル:<0.10 EU per 1 µg of the protein by the LAL method.
別名:Hematopoietin-1
Genbank No: 3552
Protein Accession No: Q53QF9
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
掲載カタログ

製品記事
関連記事

[在庫・価格 :2024年05月20日 08時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

IL-1α, Human, Recombinant

文献数: 50

説明文 産生:E. coli,純度:>97%, by SDS-PAGE under reducing conditions and visualized by silver stain,由来動物:Human,M.W.:18 kDa,Genbank:3552,エンドトキシンレベル:<0.10 EU per 1 µg of the protein by the LAL method.
別名:Hematopoietin-1
Genbank No: 3552
Protein Accession No: Q53QF9
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
掲載カタログ

製品記事
関連記事

IL-1α, Human, Recombinant, Carrier-free

文献数: 0

説明文 産生:E. coli,純度:>97%, by SDS-PAGE under reducing conditions and visualized by silver stain,由来動物:Human,M.W.:18 kDa,Genbank:3552,エンドトキシンレベル:<0.10 EU per 1 µg of the protein by the LAL method.
別名:Hematopoietin-1
Genbank No: 3552
Protein Accession No: Q53QF9
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
掲載カタログ

製品記事
関連記事

バルク注文に関して

バルク包装品も承ります。お気軽にお問合せ下さい。

目次に戻る

CF(Carrier-Free)とは?

R&D Systems社組換え体タンパク質製品では通常ウシ血清アルブミン(BSA)をキャリアタンパク質として加えています。キャリアタンパク質を加えることで組換え体タンパク質の安定性が高まり、使用期限が長くなります。また、より濃度の低い溶液での保管も可能となります。CF製品はBSAが含まれない製品となります。一般的に細胞培養や、ELISAのスタンダードにはBSA含有製品を推奨しています。CF製品はBSAが影響してしまうアプリケーションに推奨されます。

目次に戻る

Product Details

Source
E. coli-derived, Ser113-Ala271
Accession
Q53QF9
Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Predicted Molecular Mass
18 kDa
Activity
Measured in a cell proliferation assay using D10.G4.1 mouse helper T cells. Symons, J.A. et al. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J.et al. (eds)

目次に戻る

Additional Information

Molecule Information
IL-1 alpha/IL-1F1
Aliases
IL1A; IL-1F1
Entrez Gene IDs
3552 (Human); 16175 (Mouse); 24493 (Rat); 397094 (Porcine)
Background
IL-1 alpha/IL-1F1
Interleukin-1 (IL-1) is a name that designates two proteins, IL-1 alpha and IL-1 beta, which are the products of distinct genes, but which show approximately 25% amino acid sequence identity and which recognize the same cell surface receptors. Although IL-1 production is generally considered to be a consequence of inflammation, recent evidence suggests that IL-1 is also temporarily upregulated during bone formation and the menstrual cycle and can be induced in response to nervous system stimulation. In response to classic stimuli produced by inflammatory agents, infections or microbial endotoxins, a dramatic increase in the production of IL-1 by macrophages and various other cells is seen. Cells in particular known to produce IL-1 include osteoblasts, monocytes, macrophages, keratinocytes, Kupffer cells, hepatocytes, thymic and salivary gland epithelium, Schwann cells, fibroblasts and glia (oligodendroglia, astrocytes and microglia).IL-1 alpha and IL-1 beta are both synthesized as 31 kDa precursors that are subsequently cleaved into proteins with molecular weights of approximately 17,000. Neither precursor contains a typical hydrophobic signal peptide sequence and most of the precursor form of IL-1 alpha remains in the cytosol of cells, although there is evidence for a membrane-bound form of the precursor form of IL-1 alpha. The IL-1 alpha precursor reportedly shows full biological activity in the EL 4 assay. Among various species, the amino acid sequence of mature IL-1 alpha is conserved 60% to 70% and human IL-1 has been found to be biologically active on murine cell lines. Both forms of IL-1 bind to the same receptors, designated type I and type II. Recent evidence suggests that only the type I receptor is capable of signal transduction and that the type II receptor may function as a decoy, binding IL-1 and thus preventing binding of IL-1 to the type I receptor.

目次に戻る

Citations

Citations of cell biology reagents in peer reviewed literature can be used as a direct measure of product quality. They can also provide crucial insightinto their use under specialized or unique experimental conditions. Because of the importance published citations have to researchers, R&D Systems personnelmanually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but alsoprovides information about sample types, species, and experimental conditions.

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.
Burton L, Chan E, Fridlyand J, Koeppen H, Li J, Lin E, Merchant M, Moffat J, Neve R, Peng J, Penuel E, Ribas A, Settleman J, Sosman J, Sutherlin DP, Wang Y, Wilson TR, Yan Y
Nature 2012 487:505-9
Species: Human
Protein Application: Bioassay


Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33.
J. Exp. Med. 2012 209:1505-17
Species: Human
Protein Application: Bioassay


Evidence for altered Wnt signaling in psoriatic skin.
Gudjonsson JE, Johnston A, Stoll SW
J. Invest. Dermatol. 2010 130:1849-59
Species: Human
Protein Application: Bioassay


Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7.
Che ZM, Jung DW, Kim J, Kim K, Kim KY, Williams D
Int. J. Cancer 2010 127:332-44
Species: Human
Protein Application: Bioassay


Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1alpha, and TNF-alpha Recapitulates Some Features of Psoriasis.
Bernard FX, Boniface K, Guillet G, Guilloteau K, Huguier V, Juchaux F, Lecron JC, Morel F, Paris I, Pedretti N
J. Immunol. 2010 184:5263-70
Species: Human
Protein Application: Bioassay


Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo.
Biancotto A, Grivel JC, Iglehart SJ, Lisco A, Lurain NS, Margolis LB, Reichelderfer PS, Vanpouille C
AIDS Res. Hum. Retroviruses 2008 24:453-62
Species: N/A
Protein Application: ELISA Standard


Development and validation of sandwich ELISA microarrays with minimal assay interference.
Crowley SA, Gonzalez RM, Seurynck-Servoss SL
J. Proteome Res. 2008 7:2406-14
Species: N/A
Protein Application: ELISA Standard


IL-10 inhibits endothelium-dependent T cell costimulation by up-regulation of ILT3/4 in human vascular endothelial cells.
Celik S, Dengler TJ, Giese T, Gleissner CA, Haemmerling S, Katus HA, Klingenberg R, Kluger MS, Konstandin M, Shankar V, Zastrow A
Eur. J. Immunol. 2007 37:177-92
Species: Human
Protein Application: Bioassay


Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
Brechter AB, Lerner UH
Arthritis Rheum. 2007 56:910-23
Species: Human
Protein Application: Bioassay


Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork.
Acott TS, Bradley JM, Chen Y, Kelley MJ, Rookhuizen D, Rose AY, Song K
Invest. Ophthalmol. Vis. Sci. 2007 48:2634-43
Species: Human
Protein Application: Bioassay


目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。